Imaging the D3 receptor in humans in vivo using [11C](+)-PHNO positron emission tomography (PET).
GlaxoSmithKline Clinical Imaging Centre, London, UK. Eugenii_A_Rabiner@gsk.com
Eugenii A
EA
Rabiner
Marc
M
Laruelle
D001921:Brain / Q000000981:diagnostic imaging* / Q000187:drug effects; D001931:Brain Mapping; D002250:Carbon Radioisotopes / Q000493:pharmacokinetics; D006801:Humans; D010078:Oxazines / Q000493:pharmacokinetics*; D049268:Positron-Emission Tomography / Q000379:methods; D050637:Receptors, Dopamine D3 / Q000187:drug effects
D002250:Carbon Radioisotopes; D010078:Oxazines; D050637:Receptors, Dopamine D3; C042631:naxagolide